Sign in

CIK 0001661059

  • Non-accelerated filer
  • Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475231247
Phone
+1 240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$140,487
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$140K 10% owner 3 filings
Date Insider Transaction Shares Price Value Owned after
2026-01-30 Shaw Kevin G. Sr VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +8,270 8,270
2025-01-31 Shaw Kevin G. Sr VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +66,125 66,125
2024-03-29 Shaw Kevin G. Sr VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +93,900 93,900
2024-01-31 Shaw Kevin G. Sr VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +66,125 66,125
2023-02-28 Shaw Kevin G. Sr VP, Legal Affairs Grant or award · Employee Stock Option (Right to Buy) +75,000 75,000

Page 1 of 1 · 5 trades